UCL Study Urges Clinician Vigilance When Prescribing Gabapentinoids for Pain

Healthcare providers must exercise heightened caution when prescribing gabapentinoids for pain management due to an increased risk of severe side effects when these medications are combined with other common drugs, according to a fresh study from University College London (UCL).

The research highlights that patients taking gabapentinoids—medications such as gabapentin and pregabalin frequently prescribed for chronic pain—face a significantly greater risk of drug poisoning if they are similarly using other medications, particularly opioids, benzodiazepines, or antidepressants. This risk arises from potential pharmacodynamic interactions that can depress central nervous system function, leading to respiratory distress, extreme sedation, or overdose.

Experts emphasize that while gabapentinoids have become increasingly common in pain management regimens worldwide, their safety profile demands careful patient screening and medication review before initiation. Clinicians are advised to consider non-pharmacological alternatives first, such as physical therapy or cognitive behavioral therapy, especially for conditions like acute-on-chronic pain, chronic musculoskeletal pain, or fibromyalgia.

The findings underscore the importance of vigilant prescribing practices, including regular monitoring for signs of adverse effects and avoiding concurrent use of central nervous system depressants unless absolutely necessary and closely supervised. Patients should be educated about the risks of combining medications and instructed to report any unusual symptoms immediately.

As prescribing patterns continue to evolve, ongoing research and updated clinical guidelines will be essential to balance effective pain relief with patient safety. Healthcare systems are encouraged to implement prescribing safeguards, such as electronic health record alerts for high-risk combinations, to reduce preventable harm.

For individuals managing chronic pain, open communication with healthcare providers about all medications—including over-the-counter drugs and supplements—is critical to minimizing risks and ensuring safe, effective treatment.